Navigation Links
Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results
Date:7/28/2009

g statements. Information identifying such important factors is contained under "Factors Affecting Forward-Looking Statements" and "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2008, as filed with the Securities and Exchange Commission. Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.

                              Lexicon Pharmaceuticals, Inc.
                                 Selected Financial Data


    Consolidated Statements of        Three Months Ended    Six Months Ended
     Operations Data                       June 30,              June 30,
                                           --------              --------
    (In thousands, except per          2009       2008       2009       2008
     share data)                       ----       ----       ----       ----
                                         (unaudited)           (unaudited)

    Revenues:
       Collaborative research        $2,787     $7,953     $6,392    $15,587
       Subscription and license
        fees                            202      1,613        765      2,872
                                        ---      -----        ---      -----
          Total revenues              2,989      9,566      7,157     18,459
    Operating expenses:
    Research and development,
     including stock-based
     compensation
     of $766, $950, $1,595 and
     $2,077, respectively            20,220     30,075     43,084     57,524
    General and administrative,
     including stock-based
     compensation                     5,551       5,877    10,425     11,759
     of $590, $633, $1,203 and
     $1,285, respectively             -----       -----    ------     ------
          Total operating expenses   25,771      35,952    53,509     69,283
                                     ----
'/>"/>
SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement
2. Millennium Pharmaceuticals Inc./Lymphoma Research Foundation funds lymphoma research
3. Quark Pharmaceuticals Announces Data Indicating Potential Utility of QPI-1007 for Treatment of Glaucoma
4. Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Norway by SpePharm
5. Sunesis Pharmaceuticals Appoints Helen S. Kim to Board of Directors
6. Hisamitsu Pharmaceutical Co., Inc. Begins Tender Offer for All Outstanding Shares of Noven Pharmaceuticals, Inc.
7. Webcast Alert: Isis Pharmaceuticals Second Quarter 2009 Financial Results Conference Call
8. UPDATE: Access Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference
9. Access Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference
10. Transcept Pharmaceuticals to Present at BMO Capital Markets Healthcare Conference on August 5, 2009
11. EPIX Pharmaceuticals, Inc. Assigns all Its Assets to Joseph F. Finn, Jr., C.P.A. for the Benefit of Its Creditors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Palo Alto, CA (PRWEB) September 17, 2014 ... with Stanford University, revealed 12 companies raising rounds of ... attended by a few hundred investors and media, was ... square foot headquarters located next to the university. The ... staff and volunteers, adjacent to StartX-QB3 Labs, a 2,000 ...
(Date:9/17/2014)... York, NY (PRWEB) September 17, 2014 ... ( http://www.drugbot.com/morcellator/ ) in laparoscopic hysterectomies and other gynecological ... reports. According to figures posted on Change.org, at least ... 17th. * , According to a recent report from ... year ago by Dr. Hooman Noorchashm, after his wife, ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Leading ... announce the launch of its new vegan and gluten-free ... extremely effective and provided the results skincare testers were ... create a gentle yet active mask that provided results, ... Louise.” , This Sugar Cane Fruit Mask combines Willow ...
(Date:9/17/2014)... Cadiz Laser Spa offers the latest, most effective ... Central Texas. The newest addition to their impressive ... the revolutionary Rejuvapen micro-needling device Cadiz Laser Spa ... wide variety of skin issues. , The treatment ... is currently offering a special package through September ...
(Date:9/17/2014)... The in vitro diagnostics (IVD) marketplace ... focusing on molecular diagnostics for conditions such as infectious ... The IVD market value is projected to be worth ... The major drivers of the market’s growth include the ... evidenced by the explosion for raid and minimally-invasive diagnostic ...
Breaking Medicine News(10 mins):Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 2Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 3Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 4Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 5Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 6Health News:Power Morcellator Petition Nears 85,000 Signatures, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Petition Nears 85,000 Signatures, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Petition Nears 85,000 Signatures, Bernstein Liebhard LLP Reports 4Health News:EcoBeauty Brand Lotus Moon Unveils New Gluten-Free Sugar Cane Fruit Mask 2Health News:Revolutionary Collagen Induction Therapy is Now Available at Cadiz Laser Spa 2Health News:World In Vitro Diagnostics Market Analysed by VPG in In-demand Research Report Available at MarketPublishers.com 2Health News:World In Vitro Diagnostics Market Analysed by VPG in In-demand Research Report Available at MarketPublishers.com 3
... Older workers benefit most from a modest health behavior ... personal coaching. University of Illinois at Chicago researchers ... interventions assessing older workers, health behaviors and outcomes. The ... an upcoming issue of the American Journal of Public ...
... April 14 (HealthDay News) -- Trying to make the best of ... cope with losing their jobs, a new United Kingdom study finds. ... with their job loss were able to see the event as ... volunteering and study. They also took a contemplative view of ...
... SEATTLE Everyone knows that eating a low-fat, low-calorie diet ... study led by researchers at Fred Hutchinson Cancer Research Center ... body fat, diet and exercise are most effective when done ... of this randomized trial, led by Anne McTiernan, M.D., Ph.D., ...
... 14, 2011 An enzyme essential for DNA replication and ... exploited as anti-cancer therapy, say researchers at The Scripps Research ... in the April 15, 2011 issue of the journal Cell, ... flap endonucleases, which are essential to the life of a ...
... of Alberta shows that for best results in stable patients ... is the key to the best outcomes. Study co-authors Mark ... Clark, researcher in the Faculty of Nursing, along with fellow ... Public Health, and Ian Paterson in the Faculty of Medicine ...
... During the winter of 2008�, a three-week armed conflict ... named "Operation Cast Lead" resulted in hundreds of rocket ... this time children and their families spent hours and ... Although the psychological effects of children,s health are ...
Cached Medicine News:Health News:Older workers benefit from high-tech, high-touch health promotion 2Health News:Good Attitude Critical When Coping With Layoff Trauma 2Health News:Study finds diet plus exercise is more effective for weight loss than either method alone 2Health News:Study finds diet plus exercise is more effective for weight loss than either method alone 3Health News:Study suggests enzyme crucial to DNA replication may provide potent anti-cancer drug target 2Health News:Study suggests enzyme crucial to DNA replication may provide potent anti-cancer drug target 3Health News:Study suggests enzyme crucial to DNA replication may provide potent anti-cancer drug target 4Health News:Heart needs work after heart attack: U of A Study challenges the notion that the heart must rest 2Health News:Teachers-based intervention provides stress resistance in war-exposed children 2
(Date:9/17/2014)... 2014 /PRNewswire-iReach/ -- ChemImage announced today the ... in the development of imaging technology used ... and diseased tissue that minimizes the learning ... lowers surgical costs and potentially enhances patient ... The clinical and scientific teams at ...
(Date:9/17/2014)... 2014  Decision Resources Group finds that ... for biologic therapy, only a proportion of ... cite patients, discomfort with biological therapy as ... followed by cost-related issues and payer restrictions. ... Janssen Biotech,s Remicade and AbbVie,s Humira are ...
(Date:9/17/2014)... Sept. 17, 2014 Prostate Oncology Specialists ... campaign to educate men about new imaging technology ... the prostate. Annually, a million men undergo random ... rectum. Multi-parametric MRI (MP-MRI) of the prostate gland is ... Men need to be fully informed of their ...
Breaking Medicine Technology:Patient Outcomes Improve When Molecular Chemical Imaging Technology Is Used to Aid Robotic Surgical Procedures, According to New White Paper 2The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 2The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 3Prostate Cancer Awareness Month - Stop Random Biopsies 2Prostate Cancer Awareness Month - Stop Random Biopsies 3
... Janam Technologies LLC, a leading ... communicate wirelessly, today announced a new mobile healthcare ... product line with antimicrobial versions of the XM66 and ... provide the healthcare sector with rugged antimicrobial devices ...
... SILVER SPRING, Md., Oct. 14 The U.S. ... that their over-the-counter (OTC) chelation products are unapproved ... violation of federal law to make unproven claims ... chelation products. (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ...
Cached Medicine Technology:Janam Introduces Mobile Healthcare Product Line 2FDA Issues Warnings to Marketers of Unapproved 'Chelation' Products 2FDA Issues Warnings to Marketers of Unapproved 'Chelation' Products 3FDA Issues Warnings to Marketers of Unapproved 'Chelation' Products 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: